Search results
Scarborough Advisors LLC Takes $1.38 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 days agoScarborough Advisors LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 8,907 shares of ...
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 2 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 19 hours agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 days agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Tri-County Times· 3 days agoAbbVie logo (PRNewsFoto/AbbVie)
2 Dividend Stocks That Could Pay You for Life | The Motley Fool
The Motley Fool· 5 days agoPeople invest in dividend stocks for various reasons. Let's consider two examples: AbbVie (ABBV...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 12 hours agoRight Now Stocks of pharma companies, particularly large ones, make excellent defensive investments...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 3 days agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 4 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
3 Biotech Stocks to Buy Now: June 2024
InvestorPlace· 6 hours agoRecently, the biotech industry has taken a bit of a slower stance toward growth. With the Covid-19 pandemic in the rearview mirror, the focus of major...